XBIO
Xenetic Biosciences·NASDAQ
--
--(--)
--
--(--)
3.96 / 10
Netural
With a fund flow rating of 7.91/10, the stock shows robust fund flow characteristics. Supportive momentum from overall, block, Small, Medium, Large, and Extra-large trends is partially offset by concerning no significant trends patterns, pointing to positive capital flow trajectory. Research analyst consensus shows divided analyst consensus, demonstrating neutral perspective. Current ratings: Neutral(100.0%) across 1 coverage providers, supported by 0.00 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Joseph PantginisNeutral
Date2025-04-09
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for XBIO?
- XBIO holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.96/10 (Netural).
